Stages:
Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2023
2023
Investing in gene tech startups to end the worst and most expensive diseases and reshape production of food and materials. Specifically: Investing in US seed stage gene tech startups improving health and industry using DNA, RNA, proteins, or cells relating to therapeutics, diagnostics, vaccines, cosmetics, food, agriculture, materials, or software
2021 - 2023
2021 - 2023
Angel investing in life science startups with strong IP
2016 - 2023
2016 - 2023
Crafted most of the company's IP portfolio. As 120 diverse inventors and 20 attorneys in 5 countries, we created 400 patent assets. https://patents.google.com/?assignee=SoundHound&sort=new&dups=language
2010 - 2016
2010 - 2016
Drafted about 45 patent families, including most of a portfolio that was acquired by Qualcomm, tested the product, developed training curricula, and supported field application engineers
2008 - 2010
2008 - 2010
Led a team developing a competitive processor IP, disbanding after finding no investor
2007 - 2008
2007 - 2008
Managed to master the marketing of a machine for mobile multimedia; namely the 388VDO video codec processor
2006 - 2007
2006 - 2007
I was the customer-facing video expert for sales of the ARC Video processing solutions.
2003 - 2006
2003 - 2006
We developed the first programmable processor architecture capable of 1080p HD decode of H.264 (AVC) and other video standards. I did architecture analysis and Verilog design, applied for two patents, wrote papers, gave talks, and evangelized our technology. The company was acquired by Micronas.
1999 - 2003
1999 - 2003
Designed a multiply-accumulator for DSP extensions to a hardware-multithreading MIPS32 processor and did FPGA prototyping, verification, and technical writing
1998 - 1999
1998 - 1999
Developed processes for testing testers